Latest News about Gilead Sciences Inc/
Recent news which mentions Gilead Sciences Inc/
From Business Journals
Gilead Sciences acquires German biotech company for $1.39 billion
December 10, 2020
From Business Journals
WHO pours cold water on Gilead's Covid drug remdesivir
November 20, 2020
From Business Journals
Potential Covid vaccine from Pfizer, BioNTech crosses major threshold
November 09, 2020
From Business Journals
Potential Covid vaccine from Pfizer, BioNTech crosses major threshold
November 09, 2020
From Business Journals
From Business Journals
Gilead's drug pricing in the crosshairs again in wake of OK to use remdesivir against Covid-19
May 04, 2020
From Business Journals
FDA clears Gilead's Covid-fighting drug remdesivir
May 01, 2020
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
2 giant biotechs have 'remarkable' meetings with Gov. Newsom — then one expands access of potential COVID drug
March 23, 2020
From Business Journals
How Bay Area drugs are tackling the COVID-19 coronavirus
March 19, 2020
From Business Journals
'This can happen to anyone': How this cell therapy pioneer, diagnosed with the coronavirus, wants to destigmatize COVID-19
March 17, 2020
From Business Journals
'This can happen to anyone': How this cell therapy pioneer, diagnosed with the coronavirus, wants to destigmatize COVID-19
March 16, 2020
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.